Company: GCL
Filing Date: 2025-09-09
Form Type: 424B3
Source: 0001213900-25-086274
Chunk: 303

Company: GCL Global Holdings Ltd
Filing Date: 2025-09-09
Form: 424B3
Chunk 303
---
,786,289 |     | $       |  252,275,930 |     | $       |  225,720,027 |
| Unaudited pro forma net income |     | $       |    8,083,117 |     | $       |    3,527,810 |     | $       |    6,557,743 |

Due to the timing of the
acquisition, the initial purchase accounting is incomplete. The Company is evaluating the potential effects of this acquisition on the
consolidated financial statements. The Ban Leong acquisition will be evaluated in accordance with ASC 805, “Business Combination”

On May 21, 2025, the Company
entered into a Securities Purchase Agreement with an investor for the issuance of a senior unsecured convertible note with an initial
principal amount of US$2.9 million, issued at a discount for a purchase price of US$2.61 million. The note bears interest at 6% per annum,
increasing to 18% upon default, and the Company may elect to settle interest payments in cash, ordinary shares, or a combination thereof,
subject to specified equity conditions. The note is convertible at the holder’s discretion into the Company’s ordinary shares
at a fixed price of US$2.16 per share, subject to customary anti-dilution adjustments. The agreement also provides the investor with
the right to purchase up to an additional US$42.6 million in convertible notes.

In connection with that
certain Facility Letter dated as of October 1, 2024, as supplemented by the Supplemental Letter dated as of March 12, 2025 and July 7,
2025 between Epicsoft Asia Pte. Ltd. (the “Borrower”), a wholly-owned subsidiary of GCL Global Holdings Ltd (the “Company”
or “GCL”), and Oversea-Chinese Banking Corporation Limited (“OCBC”) for a financing of up to SGD5,000,000 (the
“Facility Agreement”), the Company issued to OCBC a warrant (the “OCBC Warrant”) to purchase up to 899,281 ordinary
shares of the Company (the “Warrant Shares”) at an exercise price of US$4.17 per share (the “Exercise Price”)
to meet one of the conditions precedent for the Borrower to draw down funds under the Facility Agreement. The aggregate Exercise Price
payable for the total number of Warrant Shares purchasable under